Songul CUGLAN, NİHAT EKİNCİ, Azibe YILDIZ, ZÜMRÜT DOĞAN, Hilal Irmak SAPMAZ, Nigar VARDI, Fatma ÖZYALIN, Sinan BAKİRCİ, MAHMUT ÇAY, EVREN KÖSE, YUSUF TÜRKÖZ, DAVUT ÖZBAĞ

The role of chrysin against harmful effects of formaldehyde exposure on the morphology of rat fetus liver and kidney development

This study was aimed to investigate possible harmful effects of formaldehyde (FA) exposure on the morphology of fetus liver and kidney development during pregnancy and also to determinate possible protective role of chrysin (CH) against these harmful effects. For this aim, after pregnancy was induced, 58 female rats were divided into 6 groups. Serum physiologic (SF) was injected to the Group I rats intraperitoneally (i.p.). 20 mg/kg CH was given to the Group II via gavage. 0.1 mg/kg FA was applied to the Group III (i.p.), 1 mg/kg FA was injected to Group IV (i.p.) 0.1 mg/kg FA was given to Group V i.p., and 20 mg/kg CH was given to the same group via gavage. 1 mg/kg FA was applied to Group VI i.p., and 20 mg/kg CH was given to the same group via gavage. Fetuses were taken from each pregnant rat with cesarean section on the 20th day of the pregnancy. The morphological analyses of the fetuses, liver and kidney; biochemical and histological analyses of the liver and kidney were performed. The fetal body, liver and kidney weight of the FA groups demonstrated a statistically significant decrease the compared to control group. Also the FA-1 group were observed histopathological changes on the fetus liver and kidneys. FA exposure causes harmful effects on fetus the liver and kidneys. CH reduces the negative effect on morphological variables statistically. Although CH is insufficient to fix the histopathological changes that occur in the liver, damaging effects that occur in the kidney decreased statistically

PDF

___

1. Fowden AL. Growth and metabolism. In: Fetal Growth and Development. 1nd edition. Cambridge: United Kingdom at the University Press, 2001;44-70.

2. Atasü T. Gebelikte Fetusa ve Yenidoğana Zararlı Etkenler. 2inci baskı, Nobel Tıp Kitabevleri, 2000;477-8.

3. Cetin E, Malas M. Fetal büyümeye etki eden çevresel faktörler. Med J SDU. 2005;12(2):65-72.

4. Sadler TW. Üçüncü ve Sekizinci Haftalar Arası: Embriyonik Dönem. Çev: Başaklar AC. Langman Medikal Embriyoloji. 11. baskıdan çeviri. Ankara: Palme Yayıncılık. 2011;67-90.

5. Hebel R, Stromberg MW. Digestive system, embryology. In: Anatomy and Embryology of the Laboratory Rat. Almanya: Biomed Verlag. 1986;46-57, 231-51.

6. Soysal H, Unur E, Duzler A, Karaca O, Ekinci N. Effects of intraperitoneal administration of the phenytoin on the skeletal system of the rat fetus. Seizure. 2011;20(3):187-93.

7. Formaldehyde. http://www.atsdr.cdc.gov/substances/toxsubstance.asp?toxid=39. access date 04.05.2012

8. Smith AE. Formaldehyde. Occup Med. 1992;42(2):83-8.

9. IARC: International Agency For Research On Cancer. Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 88 (2006). Formaldehyde, 2-Butoxyethanol and and 1-tert-Butoxy–2- propanol. http://monographs.iarc.fr/ENG/Monographs/vol88/mono88.pdf. access date 06.05.2012

10. Unsaldi E, Ciftci MK. Formaldehyde, usage areas, risk group, harmful effects and preventive measures.YYÜ, Journal of Faculty of Veterinary Medicine. 2010;21(1):71-5.

11. Report of the Federal Panel on formaldehyde. Environ Health Perspect. 1982;43:139-68.

12. Chapter 5.8 Formaldehyde. http://www.euro.who.int/__data/assets/pdf_file/0014/123062/AQG2n dEd_5_8Formaldehyde.pdf. access date 12.06.2012

13. Taskinen HK, Kyyronen P, Sallmen M, Virtanen SV, Liukkonen TA, Huida O, Lindbohm ML, Anttila A. Reduced fertility among female wood workers exposed to formaldehyde. Am J Indust Med. 1999;36(1):206-12.

14. Duong A, Steinmaus C, McHale CM, Vaughan CP, Zhang L. Reproductive and developmental toxicity of formaldehyde: A systematic review. Mutat Res. 2011;728(3):118-38.

15. Maroziene L, Grazuleviciene R. Maternal exposure to low-level air pollution and pregnancy outcomes: a population-based study. Environ Health. 2002;1(1):6.

16. Collins JJ, Ness R, Tyl RW, Krivanek N, Esmen NA, Hall TA. A review of adverse pregnancy outcomes and formaldehyde exposure in human and animal studies. Regul Toxicol Pharmacol. 2001;34(1):17- 34.

17. Dulskiene V, Grazuleviciene R. Environmental risk factors and outdoor formaldehyde and risk of congenital heart malformations. Medicina (Kaunas). 2005;41(9):787-95.

18. Overman DO. Absence of embryotoxic effects of formaldehyde afterpercutaneous exposure in hamsters. Toxicol Lett. 1985;24(1):107-10.

19. Saillenfait AM, Bonnet P, de Ceaurriz J. The effects of maternally inhaled formaldehyde on embryonal and foetal development in rats. Food Chem Toxicol. 1989;27(8):545-8.

20. Martin WJ. A teratology study of inhaled formaldehyde in the rat. Reprod Toxicol. 1990;4(3):237-9.

21. Thrasher JD, Kilburn KH. Embryo toxicity and teratogenicity of formaldehyde. Arch Environ Health. 2001;56(4):300-11.

22. Al-Saraj AA. Teratogenic effect of formaldehyde in rabbits. Iraqi J. Vet. Sci.2009;23:1-4.

23. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74(4):418– 25.

24. Ciftci O, Vardi N, Ozdemir I. Effects of Quercetin and Chrysin on 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induced Hepatotoxicity in Rats. Inc. Environ Toxicol. 2013;28(3):146-54.

25. Wang X, Morris ME. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. Drug Metab Dispos. 2007;35(2):268-74.

26. de Groot H, Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol. 1998;12(3):249-55.

27. Fishkin RJ, Winslow JT. Endotoxin-induced reduction of social investigation by mice interaction with amphetamine and antiinflammatory drugs. Psychopharmacol. 1997;132(4): 335-41.

28. Pearce FL, Befus AD, Bienenstock J. Mucosal mast cells. III. Effect of quercetin and other flavonoids on antigen-induced histamine secretion from rat intestinal mast cells. J Allergy Clin Immunol. 1984;73:819-23.

29. Kubo I, Kinst-Hori I, Chaudhuri SK, Kubo Y, Sánchez Y, Ogura T. Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria. Bioorg Med Chem. 2000;8(7):1749-55.

30. Villar IC, Jiménez R, Galisteo M, Garcia-Saura MF, Zarzuelo A, Duarte J. Effects of chronic chrysin treatment in spontaneously hypertensive rats. Planta Med. 2002;68(9):847-50.

31. Monasterio, A, Urdaci, MC, Pinchuk, IV, Lopez-Moratalla, N, Martinez-Irujo, JJ. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr. Cancer. 2004;50(1):90-100.

32. Zhang T, Chen X, Qu L, Wu J, Cui R, Zhao Y. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells.Bioorg. Med. Chem. 2004;12(23):6097-105.

33. Khoo BY, Chua SL, Balaram P. Apoptotic Effects of Chrysin in Human Cancer Cell Lines. Int. J. Mol. Sci. 2010;11(5):2188-99.

34. Di Luzio NR, Hartman AD. Role of lipid peroxidation in the pathogenesis of ethanol-induced fatty liver. Fed Proc. 1967;26(5):1436-42.

35. Zhang Q, Zhao XH, Wang ZJ. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE510) by induction of G2/M arrest and apoptosis. Toxicol. In Vitro. 2009;23(5):797-807.

36. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys. 1959;82(1):70-7.

37. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-69.

38. Ohkawa H, Ohiski N, Yagi K. Assay of lipid peroxides in animal tissue by thiobarbutiric acid reaction. Anal Biochemi. 1979;95(2):351-8.

39. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988;34(3):497-500.

40. Aebi H. Catalase. In: Bergmeyer HU, ed, Methods of Enzymatic Analysis. New York and London: Academic Press Inc.1974;673-7.

41. Uzun H, Uludag S, Guralp O, Topçuoglu A. Gebelikte Oksidatif Stres ve Stres Bulguları. Jinekoloji ve Obstetrik Dergisi. 2008;22(1):3-14.

42. Pushpavalli G, Kalaiarasi P, Veeramani C, Pugalendi KV. Effect of chrysin on hepatoprotective and antioxidant status in Dgalactosamine-induced hepatitis in rats. Eur J Pharmacol 2010;631(1- 3):36–41.

43. Sathiavelu J, Senapathy GJ, Devaraj R, Namasivayam N. Hepatoprotective effect of chrysin on prooxidant–antioxidant status during ethanol-induced toxicity in female albino rats. J Pharm Pharmacol. 2009;61(6):809–17.

44. Finaud J, Lac G, Filaire E. Oxidative stress relationship with exercise and training. Sports Med. 2006;36(4):327-58.

45. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 2001;31(11):1287-312.

46. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cellular Signalling. 2007;19(9):1807-19.

47. Davies KJ, Delsignore ME. Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J Biol Chem. 1987;262(20):9908-13.

48. Sanchez AR, Almeida A, Medina JM. Oxidative stress in preterm rat brain is due to mitochondrial dysfunction. Pediat Res. 2002;51(1):34– 9.

49. Akkus I. Free radicals and pathophysiologic effects. Konya: Mimosa Publications.1995;32:1-76.

50. Yalcın AS. Antioxidants. Clinical Development. 1998;11(1-2):342-6.

51. Gulec M, Gurel A, Armutcu F. Vitamin E Protects Against Oxidative Damage Caused by Formaldehyde in the Liver and Plasma of Rats. Mol Cellr Biochem. 2006;290(1-2):61-7.

52. Datta NJ, Namasivayam A. In vitro effect of methanol on folate deficient rat hepatocytes. Drug Alcohol Depend. 2003;71(1):87-91.

53. Fang YZ, Yang S, Wu G. Free radicals, antioxidant and nutrition. Nutrition. 2002;18 (10):872-9.

54. Akpoyraz M, Durak I. Biological foundations of free radicals. Ankara J Med.1995;48(2):253-62.

55. Sozmen EY. Biochemistry of aging. Onat T, Emerk K, E.Y. Sözmen EY, eds, İnsan Biyokimyası. Ankara: Palme Yayıncılık. 2002;665- 674.

56. Meister A, Larsson A. Glutathione synthetase deficiency and other disorders of the gama-glutamyl cycle. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds, The metabolic basis of inherited disease. 6th edition. New York: McGraw-Hill. 1989:855-68.

57. Martensson J, Lai JCK and Meister A. High affinity transport of glutathione is part of a multi-component system essential for mitochondrial function. Proc Natl Acad Sci. 1990;87(18):7185-9.

58. Reed DJ, Fariss MW. Glutathione depletion and susceptibility. Pharmacol Rev. 1994;36:235-335.

59. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res. 1999;31(4):273-300.

60. Teng S, Beard K,Pourahmad J, Moridani M, Easson E, Poon R, O'Brien PJ. The formaldehyde metabolic detoxification enzyme systems and molecular cytotoxic mechanism in isolated rat hepatocytes. Chem Biol Interact. 2001;30;130-132(1-3):285-96.

61. Zararsiz I, Sonmez MF, Yilmaz HR, Tas U, Kus I, Kavakli A, Sarsilmaz M. Effects of omega-3 essential fatty acids against formaldehyde-induced nephropathy in rats.Toxicol Ind Health. 2006;22(5):223-9.

62. Bakar E, Ulucam E, Cerkezkayabekir A. Investigation of the protective effects of proanthocyanidin and vitamin E against the toxic effect caused by formaldehyde on the liver tissue. Environ Toxicol. 2015;30(12):1406-15.